U.S. Retail Distributors Stock News

NYSE:UNM
NYSE:UNMInsurance

Is It Time To Reconsider Unum Group (UNM) After A 215% Five Year Share Price Surge

If you are wondering whether Unum Group's share price still offers value, the recent performance gives you a lot to think about. The stock last closed at US$77.76, with a 1.5% decline over 7 days, a 5.3% gain over 30 days, a 0.7% return year to date, a 0.9% return over 1 year, 103.9% over 3 years and a very large 214.7% over 5 years. Recent coverage has focused on Unum Group as a US insurance name that investors watch for its mix of protection products and group benefits. This often draws...
NasdaqGS:ZG
NasdaqGS:ZGReal Estate

Assessing Zillow Group (ZG) Valuation After Recent Share Price Weakness

Recent share performance and what it might signal Zillow Group (ZG) has seen its share price under pressure recently, with a 34% decline over the past 3 months and a 32% drop year to date, bringing the latest close to $44.50. Over the past year, the total return stands at a 31% decline, while the 3 year total return is 7% and the 5 year total return reflects a 67% decline, giving investors a mixed picture of longer term performance. These moves come as Zillow Group reports annual revenue of...
NasdaqGM:USAR
NasdaqGM:USARMetals and Mining

Has USA Rare Earth (USAR) Risen Too Far After Recent Critical Minerals Spotlight?

Investors may be wondering whether USA Rare Earth's current share price reflects its fundamental worth, or if recent excitement has pushed it ahead of the underlying value story. The stock last closed at US$23.09, with returns of 25.3% over 7 days, 39.1% over 30 days, 63.2% year to date and 74.5% over 1 year. This naturally raises questions about how much of the valuation case is already reflected in the price. Recent coverage of USA Rare Earth's role in supplying materials that are...
NYSE:RTX
NYSE:RTXAerospace & Defense

Assessing RTX (RTX) Valuation After Recent Pullback And Conflicting Fair Value Signals

RTX stock snapshot and recent performance RTX (RTX) shares recently closed at US$179.30, with returns showing a 0.9% decline on the day, an 8.5% decline over the past week, and an 8.6% decline over the past 3 months. Despite these shorter term moves, RTX reports annual revenue of US$90.4b and net income of US$7.3b. Revenue and net income growth are stated at 5.5% and 9.8% respectively, figures many investors watch when reassessing core aerospace and defense holdings. See our latest analysis...
NYSE:BE
NYSE:BEElectrical

Bloom Energy (BE) Is Up 13.1% After Major Oracle AI Data Center Fuel Cell Deal - Has The Bull Case Changed?

Earlier in April 2026, Bloom Energy announced an expanded partnership with Oracle, which now plans to procure up to 2.8 GW of Bloom’s fast-deploying solid-oxide fuel cell systems to power U.S. AI and cloud data centers under a master services agreement. This deal not only highlights Bloom’s ability to deliver onsite, load-following power tailored for high-density AI workloads, but also signals growing acceptance of distributed fuel cell generation as a core piece of modern digital...
NYSE:EPRT
NYSE:EPRTREITs

FFO Growth At Essential Properties Realty Trust (EPRT) Tests Long Lease Stability Narrative

Essential Properties Realty Trust (EPRT) has kicked off Q1 2026 with total revenue of US$158.8 million, basic EPS of US$0.28 and net income of US$59.8 million, with management and investors also watching FFO of US$114.6 million and FFO per share of US$0.54 as key REIT metrics. Over the past year, the company has seen revenue move from US$129.4 million and basic EPS of US$0.30 in Q1 2025 to US$158.8 million and US$0.28 in the latest quarter, while trailing twelve month revenue reached US$590.7...
NasdaqGM:IRON
NasdaqGM:IRONBiotechs

Will Insider 10b5-1 Sales and New ASCO Data Shift Disc Medicine's (IRON) Narrative?

Disc Medicine recently reported that its Chief Medical Officer, William Jacob Savage, sold 5,731 shares under a pre-arranged 10b5-1 trading plan while its lead program, bitopertin, continues in the Phase 3 APOLLO study with topline data expected later this year. Separately, the company said it will present new Phase 2 RALLY-MF trial data for DISC-0974 in anemia of myelofibrosis at the upcoming ASCO Annual Meeting, building on earlier results that showed unusually strong anemia response rates...
NasdaqGS:ADI
NasdaqGS:ADISemiconductor

Is Analog Devices’ (ADI) Upgraded Outlook and Fund Backing Reframing Its Earnings Power Story?

In recent weeks, Analog Devices announced it will report its fiscal second-quarter 2026 results on May 20, 2026, alongside a management conference call to discuss performance and business outlook, while analysts have raised earnings estimates and given the stock a favorable Zacks Rank of #2. An additional angle is that prominent fund manager Steven Romick now holds Analog Devices as a meaningful 5.65% position in his FPA Crescent Fund portfolio, underscoring growing institutional attention...
NasdaqGS:XP
NasdaqGS:XPCapital Markets

Is XP (NasdaqGS:XP) Still Offering Value After Mixed Recent Share Price Moves

If you are wondering whether XP at around US$19.63 is still offering value or already pricing in the story, you are not alone. The stock has seen mixed moves recently, with a 7.1% decline over the past week, a 2.1% gain over 30 days, and returns of 21.3% year to date and 27.4% over the last year that may be reshaping how investors think about its risk and reward. Recent news coverage around XP has largely focused on its role in Brazil's capital markets and its position in the broader...
NYSE:NVRI
NYSE:NVRICommercial Services

Assessing Enviri (NVRI) Valuation After Strong 1 Year Return And Ongoing Turnaround Efforts

Enviri stock snapshot Enviri (NVRI) has drawn attention after recent share price moves, with investors weighing its month and past 3 months returns against ongoing losses, segment mix and value indicators such as its current value score. See our latest analysis for Enviri. At a share price of $19.44, Enviri has seen its 30 day share price return of 5.65% build on an 8.60% year to date share price return. The 1 year total shareholder return of 191.45% and 3 year total shareholder return of...
NasdaqGM:CRSP
NasdaqGM:CRSPBiotechs

Is CRISPR Therapeutics (CRSP) Share Price Aligning With Its Long Term Growth Story?

Wondering whether CRISPR Therapeutics at US$55.18 is priced for its potential or already demanding a premium? This article focuses squarely on what the current market value might be telling you. The stock has seen a 41.1% return over the last year, with a 30 day return of 18.8%, while also showing shorter term volatility such as a 1% decline over the last week and a 5 year return of negative 58.2%. Recent headlines around CRISPR Therapeutics continue to keep attention on the company,...
NYSE:TYL
NYSE:TYLSoftware

Did Lake County’s Mobile Rollout Just Shift Tyler Technologies’ (TYL) Government Cloud Adoption Narrative?

Tyler Technologies, Inc. recently announced that the Lake County Sheriff’s Office in Illinois has gone live with its Enterprise Public Safety suite, including Enforcement Mobile, Civil Serve, and Corrections Mobile, giving officers real-time access to digital records and reducing manual data entry. This rollout shows how Tyler’s mobile and cloud-based tools can materially reshape daily workflows for a large public safety agency serving more than 720,000 residents. Next, we’ll examine how...
NYSE:RYAN
NYSE:RYANInsurance

Is Ryan Specialty Holdings (RYAN) Pricing Look Interesting After Recent Share Price Weakness?

Wondering whether Ryan Specialty Holdings at US$35.40 is starting to look interesting on price, or if the recent weakness is a warning sign? This article breaks down what the current valuation is actually telling you. The stock has seen a 5.3% decline over the last 7 days, a 5.6% gain over the last 30 days, and returns of 30.1% decline year to date and 48.7% decline over the last year. This raises questions about how sentiment and risk are shifting around the name. Recent coverage has...
NYSE:TME
NYSE:TMEEntertainment

Is Tencent Music Entertainment Group (NYSE:TME) Pricing Reflect Recent Slide And DCF Upside Potential

If you are wondering whether Tencent Music Entertainment Group's current share price reflects its underlying value, or if the market is mispricing it, this breakdown will help you frame that question with numbers rather than guesswork. The stock last closed at US$9.25, with returns of an 8.9% decline over 7 days, a 6.2% decline over 30 days, a 48.2% decline year to date, a 28.6% decline over 1 year, a 32.8% gain over 3 years, and a 45.6% decline over 5 years, which gives you a wide range of...
NYSE:FAF
NYSE:FAFInsurance

First American Financial (FAF) Margin Rebound Tests Bullish Profitability Narratives Ahead Of Q1 2026

First American Financial (FAF) has followed up its earnings rebound with trailing 12‑month revenue of about US$7.5 billion and basic EPS of US$6.02, alongside year‑over‑year reported earnings growth of very roughly 4x and a net profit margin of 8.3% versus 2.1% a year earlier. The company has seen quarterly revenue move from US$1,406.1 million in Q3 2024 to US$1,685.1 million in Q4 2024 and then to US$2,049.7 million in Q4 2025, with basic EPS shifting from a loss of US$1.00 in Q3 2024 to...
NYSE:LHX
NYSE:LHXAerospace & Defense

L3Harris Missile Unit Draws US$1b Investment And Potential IPO Rerating

L3Harris Technologies (NYSE:LHX) received a $1b investment from the Department of War into its Missile Solutions business. The funding is structured as a convertible preferred security that is set to convert to equity at a planned IPO of the Missile Solutions unit. Capital is earmarked for facility expansion, R&D, and national security production within the missile segment. L3Harris is a major defense contractor with a focus on communications, mission systems, and missile related...
NYSE:MKL
NYSE:MKLInsurance

Is Markel Group (MKL) Pricing Reflect Its Mixed Returns And Intrinsic Value Estimates

Wondering if Markel Group at around US$1,929.91 is offering fair value or a potential mispricing opportunity? This article walks through the key numbers so you can judge for yourself. The stock has seen mixed returns, with a 1.9% decline over the last 7 days, a 1.7% gain over 30 days, and a 6.7% return over 1 year. The longer 3 year and 5 year returns sit at 45.8% and 64.4% respectively. These moves sit against a backdrop of ongoing attention on Markel Group as an insurance and investment...
NasdaqGS:AMZN
NasdaqGS:AMZNMultiline Retail

Lawsuit Over Defective Camp Stove Tests Amazon Marketplace Risk Story

A new personal injury lawsuit in Washington state alleges Amazon sold a defective camp stove that caused catastrophic burns. The complaint claims Amazon knew about safety risks, continued to list the product as a top seller and did not take adequate corrective action. The case raises questions about Amazon’s responsibility for third party marketplace products and its processes for handling safety complaints. This comes at a time when Amazon.com, ticker NasdaqGS:AMZN, has seen strong recent...
NasdaqGS:AMSC
NasdaqGS:AMSCElectrical

Is It Too Late To Consider American Superconductor (AMSC) After A 129% One-Year Surge?

Wondering if American Superconductor at around US$46.15 is still offering value or if the easy money has already been made? This article breaks down what the current price might really imply. The stock has seen sharp moves recently, with returns of 21.5% over 7 days, 43.3% over 30 days, 46.1% year to date and 129.3% over 1 year, along with a very large 3 year return that sits above 7x. These moves come as American Superconductor continues to attract attention from investors looking at power...
NasdaqGS:TROW
NasdaqGS:TROWCapital Markets

Assessing T. Rowe Price (TROW) Valuation After Expanded 55ip Tax Optimization Partnership

Fresh attention is turning to T. Rowe Price Group (TROW) after 55ip, a J.P. Morgan subsidiary, expanded its collaboration with the asset manager to deliver tax-focused custom model portfolios for financial advisors. See our latest analysis for T. Rowe Price Group. The dual-share class approval and the expanded 55ip partnership come as T. Rowe Price Group’s share price sits at US$99.49, with a 12.04% 1 month share price return but a 5 year total shareholder return of negative 31.28%. This...
NYSE:UHS
NYSE:UHSHealthcare

A Look At Universal Health Services (UHS) Valuation As Earnings And Revenue Expectations Improve

Upcoming earnings expectations and why they matter for Universal Health Services Universal Health Services (UHS) is back in focus as analysts expect quarterly earnings of $5.36 per share and revenue of $4.37 billion, with projections pointing to higher net revenues and admissions across both core segments. See our latest analysis for Universal Health Services. The share price has eased in recent months, with a 30 day share price return of a 2.55% decline and a 90 day share price return of an...
NYSE:KMI
NYSE:KMIOil and Gas

Kinder Morgan (KMI) Margin Strength And 17% Earnings Growth Test Bullish Narratives

Kinder Morgan (KMI) opened 2026 with Q1 results that build on a solid recent run, with Q4 2025 revenue at US$4.5 billion and basic EPS of US$0.45 supported by net income of US$991 million. Over the past few quarters, revenue has moved from US$3.7 billion in Q3 2024 to US$4.0 billion in Q2 2025 and US$4.5 billion in Q4 2025, while basic EPS shifted from US$0.28 to US$0.32 and then to US$0.45. Together, these figures give you a clear sense of the recent earnings trajectory. With a trailing net...
NYSE:LYB
NYSE:LYBChemicals

A Look At LyondellBasell (LYB) Valuation After Its Recent Share Price Rebound

What LyondellBasell Industries (LYB) shareholders are reacting to LyondellBasell Industries (LYB) shares have seen mixed recent performance, with a one-month return of about a 7% decline and a gain of nearly 39% over the past three months, putting the stock on many investors’ radar. See our latest analysis for LyondellBasell Industries. The recent 6.9% 30 day share price decline contrasts with a 38.7% 90 day share price return and a 59.3% year to date share price return, while the 1 year...